Approval · Notice of Compliance 22746 · 2019
DYMISTA: Notice of Compliance 22746
Issued October 4, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22746
- Date
- October 4, 2019
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a pediatric indication
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DYMISTA | Not yet assigned | — |
Medicinal ingredients
- FLUTICASONE PROPIONATE 50 MCG per ACT
- AZELASTINE HYDROCHLORIDE 137 MCG per ACT